Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.z

An area or areas of consolidation

Publications

Decavèle M, Pichon J, Fajac A, Milon A, Antoine M, Gibelin A, Parrot A, Fartoukh M

Case 327: Exogenous Lipoid Pneumonia.

Radiology. 2024;312(1):e222280

Harris K, Chalhoub M, Maroun R, Abi-Fadel F, Zhao F

Lipoid pneumonia: a challenging diagnosis.

Heart & lung : the journal of critical care. 2011;40(6):580-4

Hadda V, Khilnani GC, Bhalla AS, Mathur S

Lipoid pneumonia presenting as non resolving community acquired pneumonia: a case report.

Cases journal. 2009;2:9332

Meltzer E, Guranda L, Perelman M, Krupsky M, Vassilenko L, Sidi Y

Lipoid pneumonia: a preventable form of drug-induced lung injury.

European journal of internal medicine. 2005;16(8):615-7

Spickard A 3rd, Hirschmann JV

Exogenous lipoid pneumonia.

Archives of internal medicine. 1994;154(6):686-92